Abstract
It has been widely assumed that the production of the ubiquitous second messenger cyclic AMP, which is mediated by cell surface G protein–coupled receptors (GPCRs), and its termination take place exclusively at the plasma membrane. Recent studies reveal that diverse GPCRs do not always follow this conventional paradigm. In the new model, GPCRs mediate G-protein signaling not only from the plasma membrane but also from endosomal membranes. This model proposes that following ligand binding and activation, cell surface GPCRs internalize and redistribute into early endosomes, where trimeric G protein signaling can be maintained for an extended period of time. This Perspective discusses the molecular and cellular mechanistic subtleties as well as the physiological consequences of this unexpected process, which is considerably changing how we think about GPCR signaling and regulation and how we study drugs that target this receptor family.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lefkowitz, R.J. Seven transmembrane receptors: something old, something new. Acta Physiol. (Oxf.) 190, 9–19 (2007).
Vilardaga, J.P., Bunemann, M., Krasel, C., Castro, M. & Lohse, M.J. Measurement of the millisecond activation switch of G protein–coupled receptors in living cells. Nat. Biotechnol. 21, 807–812 (2003).
Nikolaev, V.O., Hoffmann, C., Bunemann, M., Lohse, M.J. & Vilardaga, J.P. Molecular basis of partial agonism at the neurotransmitter a2A-adrenergic receptor and Gi-protein heterotrimer. J. Biol. Chem. 281, 24506–24511 (2006).
Lohse, M.J. et al. Optical techniques to analyze real-time activation and signaling of G-protein–coupled receptors. Trends Pharmacol. Sci. 29, 159–165 (2008).
Vilardaga, J.P., Romero, G., Feinstein, T.N. & Wehbi, V.L. Kinetics and dynamics in the G protein–coupled receptor signaling cascade. Methods Enzymol. 522, 337–363 (2013).
Farahbakhsh, Z.T., Hideg, K. & Hubbell, W.L. Photoactivated conformational changes in rhodopsin: a time-resolved spin label study. Science 262, 1416–1419 (1993).
Hoffmann, C. et al. A FlAsH-based FRET approach to determine G protein–coupled receptor activation in living cells. Nat. Methods 2, 171–176 (2005).
Ferrandon, S. et al. Sustained cyclic AMP production by parathyroid hormone receptor endocytosis. Nat. Chem. Biol. 5, 734–742 (2009).
Hein, P., Frank, M., Hoffmann, C., Lohse, M.J. & Bunemann, M. Dynamics of receptor/G protein coupling in living cells. EMBO J. 24, 4106–4114 (2005).
Bünemann, M., Frank, M. & Lohse, M.J. Gi protein activation in intact cells involves subunit rearrangement rather than dissociation. Proc. Natl. Acad. Sci. USA 100, 16077–16082 (2003).
Galés, C. et al. Probing the activation-promoted structural rearrangements in preassembled receptor–G protein complexes. Nat. Struct. Mol. Biol. 13, 778–786 (2006).
Gales, C. et al. Real-time monitoring of receptor and G-protein interactions in living cells. Nat. Methods 2, 177–184 (2005).
Vilardaga, J.P. et al. GPCR and G proteins: drug efficacy and activation in live cells. Mol. Endocrinol. 23, 590–599 (2009).
Lambert, N.A. Dissociation of heterotrimeric G proteins in cells. Sci. Signal. 1, re5 (2008).
Benovic, J.L., Mayor, F. Jr., Somers, R.L., Caron, M.G. & Lefkowitz, R.J. Light-dependent phosphorylation of rhodopsin by β-adrenergic receptor kinase. Nature 321, 869–872 (1986).
Goodman, O.B. Jr. et al. b-arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor. Nature 383, 447–450 (1996).
Lohse, M.J., Nuber, S. & Hoffmann, C. Fluorescence/bioluminescence resonance energy transfer techniques to study G-protein–coupled receptor activation and signaling. Pharmacol. Rev. 64, 299–336 (2012).
Calebiro, D. et al. Persistent cAMP signals triggered by internalized G-protein–coupled receptors. PLoS Biol. 7, e1000172 (2009).
Mullershausen, F. et al. Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors. Nat. Chem. Biol. 5, 428–434 (2009).
Kuna, R.S. et al. Glucagon-like peptide-1 receptor–mediated endosomal cAMP generation promotes glucose-stimulated insulin secretion in pancreatic β-cells. Am. J. Physiol. Endocrinol. Metab. 305, E161–E170 (2013).
Merriam, L.A. et al. Pituitary adenylate cyclase 1 receptor internalization and endosomal signaling mediate the pituitary adenylate cyclase activating polypeptide-induced increase in guinea pig cardiac neuron excitability. J. Neurosci. 33, 4614–4622 (2013).
Feinstein, T.N. et al. Noncanonical control of vasopressin receptor type 2 signaling by retromer and arrestin. J. Biol. Chem. 288, 27849–27860 (2013).
Irannejad, R. et al. Conformational biosensors reveal GPCR signalling from endosomes. Nature 495, 534–538 (2013).
Kotowski, S.J., Hopf, F.W., Seif, T., Bonci, A. & von Zastrow, M. Endocytosis promotes rapid dopaminergic signaling. Neuron 71, 278–290 (2011).
Luttrell, L.M. Minireview: More than just a hammer: ligand 'bias' and pharmaceutical discovery. Mol. Endocrinol. 28, 281–294 (2014).
Irannejad, R., Kotowski, S.J. & von Zastrow, M. Investigating signaling consequences of GPCR trafficking in the endocytic pathway. Methods Enzymol. 535, 403–418 (2014).
von Zastrow, M. & Williams, J.T. Modulating neuromodulation by receptor membrane traffic in the endocytic pathway. Neuron 76, 22–32 (2012).
Steyaert, J. & Kobilka, B.K. Nanobody stabilization of G protein–coupled receptor conformational states. Curr. Opin. Struct. Biol. 21, 567–572 (2011).
Perry, S.J. et al. Targeting of cyclic AMP degradation to β2-adrenergic receptors by β-arrestins. Science 298, 834–836 (2002).
Ghanouni, P., Steenhuis, J.J., Farrens, D.L. & Kobilka, B.K. Agonist-induced conformational changes in the G-protein–coupling domain of the β2 adrenergic receptor. Proc. Natl. Acad. Sci. USA 98, 5997–6002 (2001).
Ghanouni, P. et al. Functionally different agonists induce distinct conformations in the G protein coupling domain of the β2 adrenergic receptor. J. Biol. Chem. 276, 24433–24436 (2001).
Clarke, W.P. What's for lunch at the conformational cafeteria? Mol. Pharmacol. 67, 1819–1821 (2005).
Vilardaga, J.P., Steinmeyer, R., Harms, G.S. & Lohse, M.J. Molecular basis of inverse agonism in a G protein–coupled receptor. Nat. Chem. Biol. 1, 25–28 (2005).
Vilardaga, J.P. et al. Conformational cross-talk between α2A-adrenergic and m-opioid receptors controls cell signaling. Nat. Chem. Biol. 4, 126–131 (2008).
Dean, T., Vilardaga, J.P., Potts, J.T. Jr. & Gardella, T.J. Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH/PTHrP receptor. Mol. Endocrinol. 22, 156–166 (2008).
Okazaki, M. et al. Prolonged signaling at the parathyroid hormone receptor by peptide ligands targeted to a specific receptor conformation. Proc. Natl. Acad. Sci. USA 105, 16525–16530 (2008).
De Lean, A., Stadel, J. & Lefkowitz, R. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase–coupled b-adrenergic receptor. J. Biol. Chem. 255, 7108–7117 (1980).
Jacobs, J.W., Kemper, B., Niall, H.D., Habener, J.F. & Potts, J.T. Jr. Structural analysis of human proparathyroid hormone by a new microsequencing approach. Nature 249, 155–157 (1974).
Hamilton, J.W. et al. The N-terminal amino-acid sequence of bovine proparathyroid hormone. Proc. Natl. Acad. Sci. USA 71, 653–656 (1974).
Suva, L.J. et al. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 237, 893–896 (1987).
Moseley, J.M. et al. Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc. Natl. Acad. Sci. USA 84, 5048–5052 (1987).
Maeda, A. et al. Critical role of parathyroid hormone (PTH) receptor-1 phosphorylation in regulating acute responses to PTH. Proc. Natl. Acad. Sci. USA 110, 5864–5869 (2013).
Castro, M., Nikolaev, V.O., Palm, D., Lohse, M.J. & Vilardaga, J.P. Turn-on switch in parathyroid hormone receptor by a two-step parathyroid hormone binding mechanism. Proc. Natl. Acad. Sci. USA 102, 16084–16089 (2005).
Sorkin, A. & von Zastrow, M. Endocytosis and signalling: intertwining molecular networks. Nat. Rev. Mol. Cell Biol. 10, 609–622 (2009).
Hoffmann, R., Baillie, G.S., MacKenzie, S.J., Yarwood, S.J. & Houslay, M.D. The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579. EMBO J. 18, 893–903 (1999).
Feinstein, T.N. et al. Retromer terminates the generation of cAMP by internalized PTH receptors. Nat. Chem. Biol. 7, 278–284 (2011).
Collins, B.M. et al. Structure of Vps26B and mapping of its interaction with the retromer protein complex. Traffic 9, 366–379 (2008).
Collins, B.M. The structure and function of the retromer protein complex. Traffic 9, 1811–1822 (2008).
Bonifacino, J.S. & Rojas, R. Retrograde transport from endosomes to the trans-Golgi network. Nat. Rev. Mol. Cell Biol. 7, 568–579 (2006).
Gidon, A. et al. Endosomal GPCR signaling turned off by negative feedback actions of PKA and v-ATPase. Nat. Chem. Biol. 10, 707–709 (2014).
Aubry, L., Guetta, D. & Klein, G. The arrestin fold: variations on a theme. Curr. Genomics 10, 133–142 (2009).
Shi, H., Rojas, R., Bonifacino, J.S. & Hurley, J.H. The retromer subunit Vps26 has an arrestin fold and binds Vps35 through its C-terminal domain. Nat. Struct. Mol. Biol. 13, 540–548 (2006).
Hierro, A. et al. Functional architecture of the retromer cargo-recognition complex. Nature 449, 1063–1067 (2007).
Lohse, M.J. et al. Receptor-specific desensitization with purified proteins. Kinase dependence and receptor specificity of β-arrestin and arrestin in the β2-adrenergic receptor and rhodopsin systems. J. Biol. Chem. 267, 8558–8564 (1992).
Lohse, M.J., Benovic, J.L., Codina, J., Caron, M.G. & Lefkowitz, R.J. β-Arrestin: a protein that regulates β-adrenergic receptor function. Science 248, 1547–1550 (1990).
Pippig, S. et al. Overexpression of β-arrestin and β-adrenergic receptor kinase augment desensitization of β 2-adrenergic receptors. J. Biol. Chem. 268, 3201–3208 (1993).
Krupnick, J.G., Goodman, O.B. Jr., Keen, J.H. & Benovic, J.L. Arrestin/clathrin interaction. Localization of the clathrin binding domain of nonvisual arrestins to the carboxy terminus. J. Biol. Chem. 272, 15011–15016 (1997).
Vilardaga, J.P. et al. Internalization determinants of the parathyroid hormone receptor differentially regulate β-arrestin/receptor association. J. Biol. Chem. 277, 8121–8129 (2002).
Malecz, N., Bambino, T., Bencsik, M. & Nissenson, R.A. Identification of phosphorylation sites in the G protein–coupled receptor for parathyroid hormone. Receptor phosphorylation is not required for agonist-induced internalization. Mol. Endocrinol. 12, 1846–1856 (1998).
Mahon, M.J., Bonacci, T.M., Divieti, P. & Smrcka, A.V. A docking site for G protein bg subunits on the parathyroid hormone 1 receptor supports signaling through multiple pathways. Mol. Endocrinol. 20, 136–146 (2006).
Wehbi, V.L. et al. Noncanonical GPCR signaling arising from a PTH receptor-arrestin-Gbg complex. Proc. Natl. Acad. Sci. USA 110, 1530–1535 (2013).
Winer, K.K. et al. Synthetic human parathyroid hormone 1–34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism. J. Clin. Endocrinol. Metab. 97, 391–399 (2012).
National Center for Advancing Translational Sciences. Long-acting parathyroid hormone analogs for treatment of hypoparathyroidism. http://www.ncats.nih.gov/research/reengineering/bridgs/projects/parathyroid.html (2014).
von Zastrow, M. & Bourne, H.R. in Basic and Clinical Pharmacology (eds. Katzung, B.G., Masters, S.B. & Trevor, A.J.) (McGraw Hill, 2009).
Vilardaga, J.P., Gardella, T.J., Wehbi, V.L. & Feinstein, T.N. Non-canonical signaling of the PTH receptor. Trends Pharmacol. Sci. 33, 423–431 (2012).
Acknowledgements
This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under award numbers R01 DK087688 and DK102495 (to J.-P.V.) and P01 DK11794 (project I to T.J.G.).
Author information
Authors and Affiliations
Contributions
J.-P.V., F.G.J.-A. and T.J.G. each contributed to the writing of this manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Vilardaga, JP., Jean-Alphonse, F. & Gardella, T. Endosomal generation of cAMP in GPCR signaling. Nat Chem Biol 10, 700–706 (2014). https://doi.org/10.1038/nchembio.1611
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchembio.1611
This article is cited by
-
Structural details of a Class B GPCR-arrestin complex revealed by genetically encoded crosslinkers in living cells
Nature Communications (2023)
-
Endosome positioning coordinates spatially selective GPCR signaling
Nature Chemical Biology (2023)
-
Spatial decoding of endosomal cAMP signals by a metastable cytoplasmic PKA network
Nature Chemical Biology (2021)
-
PAC1 Receptor Internalization and Endosomal MEK/ERK Activation Is Essential for PACAP-Mediated Neuronal Excitability
Journal of Molecular Neuroscience (2021)
-
Phosphodiesterase 2A2 regulates mitochondria clearance through Parkin-dependent mitophagy
Communications Biology (2020)